Skip to content
DataLookout
Menu

Prev-CPENCT05798351

Rectal Carriage of Carbapenemase Producing-Enterobacteriaceae on Admission to a French University Teaching Hospital

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 8 words Show 6 more changesShow less
    • Trial completed
    • Final enrollment: 755 participants (planned 1195)
    • Primary completion date changed from estimate of May 31, 2026 to Oct 2, 2026
    • Study completion date changed from estimate of Dec 31, 2026 to Nov 2, 2026
    • Study description expanded, about 13 words
    • Site details revised
  2. Notable Primary completion date: Dec 31, 2024 to May 31, 2026
    • Study completion date: Jul 31, 2025 to Dec 31, 2026
    v4
  3. Notable Primary completion date: Jul 31, 2023 to Dec 31, 2024
    • Study completion date: Jul 31, 2023 to Jul 31, 2025
    v3
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 1, 2023 to Apr 3, 2023
    v2
  5. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Percentage of patients with CPE carriage
Timeframe: 72 hours

Secondary (5)

Percentage of patients with ESBLE carriage
Odds ratios associated with risk factors for CPE and ESBLE carriage on admission to hospital
Annual number of patients with rectal CPE carriage among those with no risk factors for CPE carriage
Annual number of secondary cases of CPE carriage that could be prevented if a universal admission screening policy was implemented
Names and percentages of bacterial species and enzymes identified in CPE screening

Sites

1 site in 1 country

  • Bichat HospitalParis, Île-de-France Region, France